
Agnieszka Boesen
Examiner (ID: 10144, Phone: (571)272-8035 , Office: P/1648 )
| Most Active Art Unit | 1648 |
| Art Unit(s) | 1671, 1672, 1648 |
| Total Applications | 1050 |
| Issued Applications | 614 |
| Pending Applications | 117 |
| Abandoned Applications | 353 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 6119151
[patent_doc_number] => 20110076672
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-03-31
[patent_title] => 'Phage-Mediated Bioluminescent Detection of Yersinia Pestis'
[patent_app_type] => utility
[patent_app_number] => 12/992488
[patent_app_country] => US
[patent_app_date] => 2009-05-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 12261
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0076/20110076672.pdf
[firstpage_image] =>[orig_patent_app_number] => 12992488
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/992488 | Phage-mediated bioluminescent detection of Yersinia pestis | May 12, 2009 | Issued |
Array
(
[id] => 8158514
[patent_doc_number] => 20120100180
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-04-26
[patent_title] => 'METHODS FOR PROLIFERATION OF ANTIGEN-SPECIFIC T CELLS'
[patent_app_type] => utility
[patent_app_number] => 13/254039
[patent_app_country] => US
[patent_app_date] => 2009-04-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 5193
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0100/20120100180.pdf
[firstpage_image] =>[orig_patent_app_number] => 13254039
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/254039 | Methods for proliferation of antigen-specific T cells | Apr 29, 2009 | Issued |
Array
(
[id] => 5392554
[patent_doc_number] => 20090209867
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-08-20
[patent_title] => 'METHOD FOR RAPID SCREENING OF MAD COW DISEASE AND OTHER TRANSMISSIBLE SPONGIFORM ENCEPHALOPATHIES'
[patent_app_type] => utility
[patent_app_number] => 12/429330
[patent_app_country] => US
[patent_app_date] => 2009-04-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 2532
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0209/20090209867.pdf
[firstpage_image] =>[orig_patent_app_number] => 12429330
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/429330 | METHOD FOR RAPID SCREENING OF MAD COW DISEASE AND OTHER TRANSMISSIBLE SPONGIFORM ENCEPHALOPATHIES | Apr 23, 2009 | Abandoned |
Array
(
[id] => 9239387
[patent_doc_number] => 08604179
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-12-10
[patent_title] => 'Nucleic acid comprising chimeric gene derived from hepatitis C virus'
[patent_app_type] => utility
[patent_app_number] => 12/989592
[patent_app_country] => US
[patent_app_date] => 2009-04-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 13462
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 157
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12989592
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/989592 | Nucleic acid comprising chimeric gene derived from hepatitis C virus | Apr 23, 2009 | Issued |
Array
(
[id] => 5391210
[patent_doc_number] => 20090208523
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-08-20
[patent_title] => 'Adjuvant for vaccines'
[patent_app_type] => utility
[patent_app_number] => 12/386753
[patent_app_country] => US
[patent_app_date] => 2009-04-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2855
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0208/20090208523.pdf
[firstpage_image] =>[orig_patent_app_number] => 12386753
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/386753 | Adjuvant for vaccines | Apr 21, 2009 | Abandoned |
Array
(
[id] => 5551869
[patent_doc_number] => 20090285855
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-11-19
[patent_title] => 'RECOMBINANT VACCINE AGAINST JAPANESE ENCEPHALITIS VIRUS (JEV) INFECTION AND A METHOD THEREOF'
[patent_app_type] => utility
[patent_app_number] => 12/426306
[patent_app_country] => US
[patent_app_date] => 2009-04-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 14233
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0285/20090285855.pdf
[firstpage_image] =>[orig_patent_app_number] => 12426306
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/426306 | RECOMBINANT VACCINE AGAINST JAPANESE ENCEPHALITIS VIRUS (JEV) INFECTION AND A METHOD THEREOF | Apr 19, 2009 | Abandoned |
Array
(
[id] => 6054619
[patent_doc_number] => 20110110979
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-05-12
[patent_title] => 'METHOD AND VACCINE FOR OPTIMIZING THE SPECIFIC IMMUNE RESPONSES'
[patent_app_type] => utility
[patent_app_number] => 12/988455
[patent_app_country] => US
[patent_app_date] => 2009-04-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 12878
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0110/20110110979.pdf
[firstpage_image] =>[orig_patent_app_number] => 12988455
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/988455 | METHOD AND VACCINE FOR OPTIMIZING THE SPECIFIC IMMUNE RESPONSES | Mar 31, 2009 | Abandoned |
Array
(
[id] => 5379732
[patent_doc_number] => 20090191571
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-07-30
[patent_title] => 'Isolation and Detection of Pathogenic Prions'
[patent_app_type] => utility
[patent_app_number] => 12/411337
[patent_app_country] => US
[patent_app_date] => 2009-03-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 31643
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0191/20090191571.pdf
[firstpage_image] =>[orig_patent_app_number] => 12411337
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/411337 | Isolation and Detection of Pathogenic Prions | Mar 24, 2009 | Abandoned |
Array
(
[id] => 4628910
[patent_doc_number] => 08007792
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-08-30
[patent_title] => 'Antibodies directed against hepatitis C virus E1E2 complex, compositions of HCV particles, and pharmaceutical compositions'
[patent_app_type] => utility
[patent_app_number] => 12/408080
[patent_app_country] => US
[patent_app_date] => 2009-03-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 32
[patent_no_of_words] => 18773
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/007/08007792.pdf
[firstpage_image] =>[orig_patent_app_number] => 12408080
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/408080 | Antibodies directed against hepatitis C virus E1E2 complex, compositions of HCV particles, and pharmaceutical compositions | Mar 19, 2009 | Issued |
Array
(
[id] => 6202308
[patent_doc_number] => 20110065094
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-03-17
[patent_title] => 'METHOD AND KIT FOR DETECTION/IDENTIFICATION OF VIRUS-INFECTED CELL'
[patent_app_type] => utility
[patent_app_number] => 12/933736
[patent_app_country] => US
[patent_app_date] => 2009-03-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 9567
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0065/20110065094.pdf
[firstpage_image] =>[orig_patent_app_number] => 12933736
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/933736 | METHOD AND KIT FOR DETECTION/IDENTIFICATION OF VIRUS-INFECTED CELL | Mar 16, 2009 | Abandoned |
Array
(
[id] => 5969110
[patent_doc_number] => 20110150912
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-06-23
[patent_title] => 'Avian influenza virus live attenuated vaccine and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 12/381550
[patent_app_country] => US
[patent_app_date] => 2009-03-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 25602
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0150/20110150912.pdf
[firstpage_image] =>[orig_patent_app_number] => 12381550
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/381550 | Avian influenza virus live attenuated vaccine and uses thereof | Mar 12, 2009 | Issued |
Array
(
[id] => 5929380
[patent_doc_number] => 20110039339
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-02-17
[patent_title] => 'Process, Vectors and Engineered Cell Lines for Enhanced Large-Scale Transfection'
[patent_app_type] => utility
[patent_app_number] => 12/989898
[patent_app_country] => US
[patent_app_date] => 2009-03-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 6370
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0039/20110039339.pdf
[firstpage_image] =>[orig_patent_app_number] => 12989898
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/989898 | Process, vectors and engineered cell lines for enhanced large-scale transfection | Mar 8, 2009 | Issued |
Array
(
[id] => 5534204
[patent_doc_number] => 20090233992
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-09-17
[patent_title] => 'HEPATITIS C VIRUS VACCINE'
[patent_app_type] => utility
[patent_app_number] => 12/396747
[patent_app_country] => US
[patent_app_date] => 2009-03-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 92
[patent_figures_cnt] => 92
[patent_no_of_words] => 22345
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12396747
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/396747 | Hepatitis C virus vaccine | Mar 2, 2009 | Issued |
Array
(
[id] => 5514287
[patent_doc_number] => 20090214593
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-08-27
[patent_title] => 'IMMUNOGEN PLATFORM'
[patent_app_type] => utility
[patent_app_number] => 12/371898
[patent_app_country] => US
[patent_app_date] => 2009-02-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 85
[patent_figures_cnt] => 85
[patent_no_of_words] => 73746
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0214/20090214593.pdf
[firstpage_image] =>[orig_patent_app_number] => 12371898
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/371898 | IMMUNOGEN PLATFORM | Feb 15, 2009 | Abandoned |
Array
(
[id] => 5403951
[patent_doc_number] => 20090239265
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-09-24
[patent_title] => 'VIRUS LIKE PARTICLES'
[patent_app_type] => utility
[patent_app_number] => 12/367195
[patent_app_country] => US
[patent_app_date] => 2009-02-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 9603
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0239/20090239265.pdf
[firstpage_image] =>[orig_patent_app_number] => 12367195
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/367195 | VIRUS LIKE PARTICLES | Feb 5, 2009 | Abandoned |
Array
(
[id] => 6125466
[patent_doc_number] => 20110086048
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-04-14
[patent_title] => 'DETECTION OF HUMAN IMMUNODEFICIENCY VIRUS CO-RECEPTOR TROPISM IN AVIREMIC SUBJECTS'
[patent_app_type] => utility
[patent_app_number] => 12/866424
[patent_app_country] => US
[patent_app_date] => 2009-02-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 7444
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0086/20110086048.pdf
[firstpage_image] =>[orig_patent_app_number] => 12866424
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/866424 | DETECTION OF HUMAN IMMUNODEFICIENCY VIRUS CO-RECEPTOR TROPISM IN AVIREMIC SUBJECTS | Feb 5, 2009 | Abandoned |
Array
(
[id] => 5533054
[patent_doc_number] => 20090232842
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-09-17
[patent_title] => 'HPV Vaccine Comprising Peptides From Host Cell Proteins'
[patent_app_type] => utility
[patent_app_number] => 12/364849
[patent_app_country] => US
[patent_app_date] => 2009-02-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 10454
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0232/20090232842.pdf
[firstpage_image] =>[orig_patent_app_number] => 12364849
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/364849 | HPV Vaccine Comprising Peptides From Host Cell Proteins | Feb 2, 2009 | Abandoned |
Array
(
[id] => 5403527
[patent_doc_number] => 20090238841
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-09-24
[patent_title] => 'HIV VACCINE FORMULATIONS'
[patent_app_type] => utility
[patent_app_number] => 12/364294
[patent_app_country] => US
[patent_app_date] => 2009-02-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 22672
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0238/20090238841.pdf
[firstpage_image] =>[orig_patent_app_number] => 12364294
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/364294 | HIV VACCINE FORMULATIONS | Feb 1, 2009 | Abandoned |
Array
(
[id] => 6195429
[patent_doc_number] => 20110027183
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-02-03
[patent_title] => 'Hydrophobic Modified Pres-Derived Peptides of Hepatitis B Virus (HBV) and Their Use as Vehicles for the Specific Delivery of Compounds to the Liver'
[patent_app_type] => utility
[patent_app_number] => 12/864197
[patent_app_country] => US
[patent_app_date] => 2009-01-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 14499
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0027/20110027183.pdf
[firstpage_image] =>[orig_patent_app_number] => 12864197
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/864197 | Hydrophobic modified pres-derived peptides of hepatitis B virus (HBV) and their use as vehicles for the specific delivery of compounds to the liver | Jan 25, 2009 | Issued |
Array
(
[id] => 6148802
[patent_doc_number] => 20110020397
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-01-27
[patent_title] => 'HYDROPHOBIC MODIFIED PRES-DERIVED PEPTIDES OF HEPATITIS B VIRUS (HBV) AND THEIR USE AS HBV AND HDV ENTRY INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 12/863663
[patent_app_country] => US
[patent_app_date] => 2009-01-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 13622
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0020/20110020397.pdf
[firstpage_image] =>[orig_patent_app_number] => 12863663
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/863663 | Hydrophobic modified pres-derived peptides of hepatitis B virus (HBV) and their use as HBV and HDV entry inhibitors | Jan 25, 2009 | Issued |